Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer's disease

Neurobiology of Aging

Volumn 32, Issue 8, 2011, Pages 1435-1442

  Ghidoni, Roberta ^a   Paterlini, Anna ^a   Albertini, Valentina ^a   Glionna, Michela ^a   Monti, Eugenio ^b   Schiaffonati, Luisa ^b   Benussi, Luisa ^a   Levy, Efrat ^c,d   Binetti, Giuliano ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

APP; Cystatin C; Electron microscopy; Exosomes; Glycosylation; Presenilin 2 mutations; SELDI TOF MS

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYSTATIN C; PRESENILIN 2;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL COMMUNICATION; EXOSOME; MOUSE; MUTATION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SECRETION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL COMMUNICATION; CELLS, CULTURED; CYSTATIN C; EXOSOMES; GLYCOSYLATION; HUMANS; MICE; NEURONS; PRESENILIN-2; PROTEIN ISOFORMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79959585860     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.08.013     Document Type: Article

References (34)

1. Abrahamson M., Grubb A., Olafsson I., Lundwall A. Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett. 1987, 216:229-233.
2. Belting M., Wittrup A. Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease. J. Cell Biol. 2008, 183:1187-1191.
3. Benussi L., Ghidoni R., Paterlini A., Nicosia F., Alberici A.C., Signorini S., Barbiero L., Binetti G. Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation. Exp. Cell Res. 2005, 308:78-84.
4. Binetti G., Signorini S., Squitti R., Alberici A., Benussi L., Cassetta E., Frisoni G.B., Barbiero L., Feudatari E., Nicosia F., Testa C., Zanetti O., Gennarelli M., Perani D., Anchisi D., Ghidoni R., Rossini P.M. A typical dementia associated with a novel presenilin-2 mutation. Ann. Neurol. 2003, 54:832-836.
5. Cho J.A., Yeo D.J., Son H.Y., Kim H.W., Jung D.S., Ko J.K., Koh J.S., Kim Y.N., Kim C.W. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int. J. Cancer 2005, 114:613-622.
6. Dahl A., Eriksson P.S., Davidsson P., Persson A.I., Ekman R., Westman-Brinkmalm A. Demonstration of multiple novel glycoforms of the stem cell survival factor CCg. J. Neurosci. Res. 2004, 77:9-14.
7. Dai S., Wei D., Wu Z., Zhou X., Wei X., Huang H., Li G. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol. Ther. 2008, 16:782-790.
8. Ekström U., Wallin H., Lorenzo J., Holmqvist B., Abrahamson M., Avilés F.X. Internalization of cystatin C in human cell lines. FEBS J. 2008, 275:4571-4582.
9. Fauré J., Lachenal G., Court M., Hirrlinger J., Chatellard-Causse C., Blot B., Grange J., Schoehn G., Goldberg Y., Boyer V., Kirchhoff F., Raposo G., Garin J., Sadoul R. Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci. 2006, 31:642-648.
10. Février B., Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 2004, 16:415-421.
11. Ghidoni R., Benussi L., Paterlini A., Missale C., Usardi A., Rossi R., Barbiero L., Spano P., Binetti G. Presenilin 2 mutations alter cystatin C trafficking in mouse primary neurons. Neurobiol. Aging 2007, 28:371-376.
12. Ghidoni R., Benussi L., Binetti G. Exosomes: the Trojan horses of neurodegeneration. Med. Hypotheses 2008, 70:1226-1227.
13. Ghidoni R., Albertini V., Squitti R., Paterlini A., Bruno A., Bernardini S., Cassetta E., Rossini P.M., Squitieri F., Benussi L., Binetti G. Novel T719P AbetaPP mutation unbalances the relative proportion of amyloid-beta peptides. J. Alzheimers Dis. 2009, (Ahead of print). 10.3233/JAD-2009-1142.
14. Huh C.G., Håkansson K., Nathanson C.M., Thorgeirsson U.P., Jonsson N., Grubb A., Abrahamson M., Karlsson S. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol. Pathol. 1999, 52:332-340.
15. Kaeser S.A., Herzig M.C., Coomaraswamy J., Kilger E., Selenica M.L., Winkler D.T., Staufenbiel M., Levy E., Grubb A., Jucker M. Cystatin C modulates cerebral beta-amyloidosis. Nat. Genet. 2007, 39:1437-1439.
16. Korant B.D., Brzin J., Turk V. Cystatin, a protein inhibitor of cysteine proteases alters viral protein cleavages in infected human cells. Biochem. Biophys. Res. Commun. 1985, 127:1072-1076.
17. Levy E. Cystatin C: a potential target for Alzheimer's treatment. Expert Rev. Neurother. 2008, 8:687-689.
18. Levy E., Sastre M., Kumar A., Gallo G., Piccardo P., Ghetti B., Tagliavini F. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer's disease patients. J. Neuropathol. Exp. Neurol. 2001, 60:94-104.
19. Levy E., Jaskolski M., Grubb A. The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models. Brain Pathol. 2006, 16:60-70.
20. Mi W., Pawlik M., Sastre M., Jung S.S., Radvinsky D.S., Klein A.M., Sommer J., Schmidt S.D., Nixon R.A., Mathews P.M., Levy E. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Nat. Genet. 2007, 39:1440-1442.
21. Palmer T.D., Schwartz P.H., Taupin P., Kaspar B., Stein S.A., Gage F.H. Cell culture. Progenitor cells from human brain after death. Nature 2001, 411:42-43.
22. Rajendran L., Honsho M., Zahn T.R., Keller P., Geiger K.D., Verkade P., Simons K. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11172-11177.
23. Sastre M., Calero M., Pawlik M., Mathews P.M., Kumar A., Danilov V., Schmidt S.D., Nixon R.A., Frangione B., Levy E. Binding of cystatin C to Alzheimer's amyloid β inhibits amyloid fibril formation. Neurobiol. Aging 2004, 25:1033-1043.
24. Schorey J.S., Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic 2008, 9:871-881.
25. Selkoe D.J. Amyloid beta protein precursor and the pathogenesis of Alzheimer's disease. Cell 1989, 58:611-612.
26. Sharples R.A., Vella L.J., Nisbet R.M., Naylor R., Perez K., Barnham K.J., Masters C.L., Hill A.F. Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. FASEB J. 2008, 22:1469-1478.
27. Sundelöf J., Arnlöv J., Ingelsson E., Sundström J., Basu S., Zethelius B., Larsson A., Irizarry M.C., Giedraitis V., Rönnemaa E., Degerman-Gunnarsson M., Hyman B.T., Basun H., Kilander L., Lannfelt L. Serum cystatin C and the risk of Alzheimer's disease in elderly men. Neurology 2008, 71:1072-1079.
28. Taupin P., Ray J., Fischer W.H., Suhr S.T., Hakansson K., Grubb A., Gage F.H. FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron 2000, 28:385-397.
29. Théry C., Amigorena S., Raposo G., Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocols in Cell Biology 2006, John Wiley and Sons Inc., New York, Chap 3: Unit 3.22. J.S. Bonifacino, M. Dasso, J.B. Harford, J. Lippincott-Schwartz, K.M. Yamada (Eds.).
30. Vella L.J., Sharples R.A., Nisbet R.M., Cappai R., Hill A.F. The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur. Biophys. J. 2008, 37:323-332.
31. Viaud S., Ullrich E., Zitvogel L., Chaput N. Exosomes for the treatment of human malignancies. Horm. Metab. Res. 2008, 40:82-88.
32. Vingtdeux V., Hamdane M., Loyens A., Gelé P., Drobeck H., Bégard S., Galas M.C., Delacourte A., Beauvillain J.C., Buée L., Sergeant N. Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J. Biol. Chem. 2007, 282:18197-18205.
33. Vinters H.V., Nishimura G.S., Secor D.L., Pardridge W.M. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am. J. Pathol. 1990, 137:233-240.
34. Zhang C., Wu B., Beglopoulos V., Wines-Samuelson M., Zhang D., Dragatsis I., Südhof T.C., Shen J. Presenilins are essential for regulating neurotransmitter release. Nature 2009, 460:632-636.